Krzysztof Kozak

Krzysztof Kozak

Auto-generated profile, based on publicly available information

Krzysztof Kozak

Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska Curie Memorial Cencer Center and Institute of Oncology, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2023 in Polish Journal of Surgery
Verified
Journal Article
Closed access
AGAleksander Grous
Aleksander Grous
SMSlawomir Mazur
Slawomir Mazur
PWPaweł Winter
Paweł Winter
KKKrzysztof Kozak
Krzysztof Kozak
AJAgnieszka Irena Jagiello-Gruszfeld
Agnieszka Irena Jagiello-Gruszfeld
ZNZbigniew Nowecki
Zbigniew Nowecki
Introduction: The use of meshes in mastectomies with immediate breast reconstruction (IBR) has become the gold standard. Aim: The use of meshes in mastectomies with immediate breast reconstruction (IBR) has become a gold standard. The purpose of the study was to analyze the complications and own experience with the use of Serasynth fully absorbable and SeragynBR partially absorbable synthetic meshes. Material and methods: In the period from December 2017 to July 2020, 118 IBR were performed in the Author's Department with the use of SeragynBR and Serasynth meshes in 93 patients operated for breast cancer. 78 Serasynth meshes (Group 1) and 40 SeragynBR meshes (Group 2) were implanted. Results: The most common complication was persistent seroma collection, which was reported in 17.9% of cases in Group 1 and 25% in Group 2. Skin inflammation was reported in 7.6% and 17.5%, while infections in 2.5% and 5% of the operated breasts in Group 1 and Group 2. Reoperation was required in 5.1% and 5% of the patients in Group 1 and Group 2. The percentage of complications was lower when Serasynth rather than Seragyn BR meshes were implanted. The frequent incidence of the seroma collection did not contribute in any significant way to serious complications such as removal of mesh/implant or infection. The complications, which developed following the implantation of both mesh types, were similar to those presented in other publications concerning mastectomy with IBR with the use of synthetic meshes. The percentage of implant losses/explanations in the discussed groups was lower than that reported in the literature. Conclusion: Despite the complications, both types of meshes can be considered as safe additions to reconstructive breast surgeries. Level of Evidence: Level III.